The cost of immunotherapy with Keytruda (pembrolizumab) in Germany typically ranges from $10,000 to $15,000. Prices depend on the dosage, number of treatment cycles, the hospital, and whether additional diagnostics or supportive therapies are needed. In the United States, the average cost is $21,500 (per NCCN). Immunotherapy with Keytruda in Germany is about 42% less expensive than in the U.S.
German hospitals usually include the medication, infusion sessions, pre-treatment blood tests, physician monitoring, and follow-up visits in the package. In the U.S., the listed price often covers only the drug itself, with separate charges for administration, lab work, and ongoing care. Patients should always confirm which services and support are included at each clinic.
Why choose Germany for immunotherapy with Keytruda (Pembrolizumab)?
Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics .
| Germany | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $10,000 | from $7,300 | from $15,000 |
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.